• 12955 Citations
  • 39 h-Index
1973 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Article

The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma

Pápai, Z., Bodoky, G., Szánté, J., Poller, I., Rahóty, P., Eckhardt, S., Láng, I. & Szendröi, M., júl. 1 2000, In : Cancer. 89, 1, p. 177-180 4 p.

Research output: Article

26 Citations (Scopus)

The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005

Van Cutsem, E., Dicato, M., Arber, N., Benson, A., Cunningham, D., Diaz-Rubio, E., Glimelius, B., Goldberg, R., Haller, D., Haustermans, K., Koo-Kang, Y., Labianca, R., Lang, I., Minsky, B., Nordlinger, B., Roth, A., Rougier, P., Schmoll, H. J., Sobrero, A., Tabernero, J. & 2 others, Szawlowski, A. & van de Velde, C., jún. 2006, In : Annals of Oncology. 17, SUPPL. 6, p. vi13-vi18

Research output: Article

26 Citations (Scopus)
9 Citations (Scopus)

Therapeutic results: report of the Hungarian children's leukaemia study group

Schuler, D., Galfi, I., Istvan, L., Kassai, P., Kemény, P., Laub, M. W., Romhányi, J., Székely, K., Velkey, L., Virág, I. & Zimonyi, I., dec. 1 1976, In : Haematologia. 10, 1, p. 51-56 6 p.

Research output: Article

1 Citation (Scopus)
3 Citations (Scopus)
6 Citations (Scopus)

Transfer factorral kezelt krónikus candidiasis esete

Nékám, K., Gürtler, A., Kalmár, L., Láng, I. & Petrányi, G., dec. 1 1975, In : Fogorvosi szemle. 68, 12, p. 369-372 4 p.

Research output: Article

3 Citations (Scopus)

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., Cameron, D., Dowsett, M., Barrios, C. H., Steger, G., Huang, C. S., Andersson, M., Inbar, M., Lichinitser, M., Láng, I., Nitz, U. & 12 others, Iwata, H., Thomssen, C., Lohrisch, C., Suter, T. M., Rüschoff, J., Süto, T., Greatorex, V., Ward, C., Straehle, C., McFadden, E., Dolci, M. S. & Gelber, R. D., okt. 20 2005, In : New England Journal of Medicine. 353, 16, p. 1659-1672 14 p.

Research output: Article

3711 Citations (Scopus)

Trastuzumab retreatment after relapse on adjuvant trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer: Final results of the retreatment after herceptin adjuvant trial

Láng, I., Bell, R., Feng, F. Y., Lopez, R. I., Jassem, J., Semiglazov, V., Al-Sakaff, N., Heinzmann, D. & Chang, J., febr. 2014, In : Clinical Oncology. 26, 2, p. 81-89 9 p.

Research output: Article

17 Citations (Scopus)

Treatment adherence and its impact on Disease-Free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequence

Chirgwin, J. H., Giobbie-Hurder, A., Coates, A. S., Price, K. N., Ejlertsen, B., Debled, M., Gelber, R. D., Goldhirsch, A., Smith, I., Rabaglio, M., Forbes, J. F., Neven, P., Láng, I., Colleoni, M. & Thürlimann, B., júl. 20 2016, In : Journal of Clinical Oncology. 34, 21, p. 2452-2459 8 p.

Research output: Article

73 Citations (Scopus)
6 Citations (Scopus)

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00

Pruneri, G., Gray, K. P., Vingiani, A., Viale, G., Curigliano, G., Criscitiello, C., Láng, I., Ruhstaller, T., Gianni, L., Goldhirsch, A., Kammler, R., Price, K. N., Cancello, G., Munzone, E., Gelber, R. D., Regan, M. M. & Colleoni, M., júl. 1 2016, In : Breast Cancer Research and Treatment. 158, 2, p. 323-331 9 p.

Research output: Article

56 Citations (Scopus)

Tumoros betegek csökkent természetes limfocitotoxicitásának fokozása transzfer faktor kezeléssel.

Láng, I., Nékám, K., Gergely, P. & Petrányi, G., ápr. 3 1983, In : Orvosi hetilap. 124, 14, p. 807-810 4 p.

Research output: Article

Twelve-month estrogen levels in premenopausal women with hormone receptor-positive breast cancer receiving adjuvant triptorelin plus exemestane or tamoxifen in the suppression of ovarian function trial (SOFT): The SOFT-EST substudy

Bellet, M., Gray, K. P., Francis, P. A., Láng, I., Ciruelos, E., Lluch, A., Climent, M. A., Catalán, G., Avella, A., Bohn, U., González-Martin, A., Ferrer, R., Catalán, R., Azaro, A., Rajasekaran, A., Morales, J., Vázquez, J., Fleming, G. F., Price, K. N. & Regan, M. M., máj. 10 2016, In : Journal of Clinical Oncology. 34, 14, p. 1584-1593 10 p.

Research output: Article

55 Citations (Scopus)
1 Citation (Scopus)

Vandetanib with docetaxel as second-line treatment for advanced breast cancer: A double-blind, placebo-controlled, randomized Phase II study

Boér, K., Láng, I., Llombart-Cussac, A., Andreasson, I., Vivanco, G. L., Sanders, N., Pover, G. M. & Murray, E., ápr. 1 2012, In : Investigational New Drugs. 30, 2, p. 681-687 7 p.

Research output: Article

33 Citations (Scopus)

VERANDERUNGEN DER ZELLULAREN IMMUNITAT UNTER DER PERITONEALDIALYSE

Taraba, I., Lang, I., Gonzalez-Cabello, R. & Petranyi, G., jan. 1 1981, In : Zeitschrift fur die Gesamte Innere Medizin und Ihre Grenzgebiete. 36, 8, p. 269-272 4 p.

Research output: Article

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

Viale, G., Regan, M. M., Dell'Orto, P., Mastropasqua, M. G., Maiorano, E., Rasmussen, B. B., MacGrogan, G., Forbes, J. F., Paridaens, R. J., Colleoni, M., Láng, I., Thürlimann, B., Mouridsen, H., Mauriac, L., Gelber, R. D., Price, K. N., Goldhirsch, A., Gusterson, B. A. & Coates, A. S., okt. 2011, In : Annals of Oncology. 22, 10, p. 2201-2207 7 p.

Research output: Article

67 Citations (Scopus)